Showing 2161-2180 of 7110 for: Cochrane Systematic Reviews Back
- Epilepsy clinics versus general neurology or medical clinics
Cochrane Systematic Reviews, 25-Oct-2008
Epilepsy is the most common serious neurological condition after stroke, with a 0.5% prevalence, and a two to three per cent life time risk of being given a diagnosis of epilepsy in the developed world.
- Epinephrine for bronchiolitis
Cochrane Systematic Reviews, 2-May-2011
Bronchodilators are commonly used for acute bronchiolitis, despite uncertain effectiveness.
- Epinephrine for the resuscitation of apparently stillborn or extremely bradycardic newborn infants
Cochrane Systematic Reviews, 17-Jan-2011
Epinephrine is a cardiac stimulant with complex effects on the heart and blood vessels. It has been used for decades in all age groups to treat cardiac arrest and bradycardia. Despite formal guidelines for the use of epinephrine in neonatal resuscitation,
- Epinephrine injection versus epinephrine injection and a second endoscopic method in high-risk bleeding ulcers
Cochrane Systematic Reviews, 9-Oct-2014
Endoscopic therapy reduces the rebleeding rate and the need for surgery in patients with bleeding peptic ulcers.
- Episiotomy for vaginal birth
Cochrane Systematic Reviews, 16-Oct-2012
Episiotomy is done to prevent severe perineal tears, but its routine use has been questioned. The relative effects of midline compared with midlateral episiotomy are unclear.
- Eradication therapy for Burkholderia cepacia complex in people with cystic fibrosis
Cochrane Systematic Reviews, 23-Oct-2014
Chronic infection with Burkholderia cepacia complex species remains a significant problem for clinicians treating people with cystic fibrosis. Colonisation with Burkholderia cepacia complex species is linked to a more rapid decline in lung function and in
- Eradication therapy for peptic ulcer disease in Helicobacter pylori positive patients
Cochrane Systematic Reviews, 6-Dec-2010
Peptic ulcer disease is the cause for dyspepsia in about 10% of patients. 95% of duodenal and 70% of gastric ulcers are associated with Helicobacter pylori. Eradication of H. pylori reduces the relapse rate of ulcers but the magnitude of this effect is un
- Ergonomic and physiotherapeutic interventions for treating work-related complaints of the arm, neck or shoulder in adults
Cochrane Systematic Reviews, 11-May-2009
Conservative interventions such as physiotherapy and ergonomic adjustments (such as keyboard adjustments or ergonomic advice) play a major role in the treatment of most work-related complaints of the arm, neck or shoulder (CANS).
- Ergonomic design and training for preventing work-related musculoskeletal disorders of the upper limb and neck in adults
Cochrane Systematic Reviews, 19-Jun-2013
Work-related upper limb and neck musculoskeletal disorders (MSDs) are one of the most common occupational disorders around the world. Although ergonomic design and training are likely to reduce the risk of workers developing work-related upper limb and ne
- Ergonomic positioning or equipment for treating carpal tunnel syndrome
Cochrane Systematic Reviews, 7-Dec-2011
Non-surgical treatment, including ergonomic positioning or equipment, are sometimes offered to people experiencing mild to moderate symptoms from carpal tunnel syndrome (CTS). The effectiveness and duration of benefit from ergonomic positioning or equipme
- Erythromycin for the prevention and treatment of feeding intolerance in preterm infants
Cochrane Systematic Reviews, 8-May-2008
Functional immaturity of gastrointestinal motility predisposes preterm infants to feeding intolerance. Erythromycin is a motilin agonist that exerts its prokinetic effect by stimulating propagative contractile activity in the interdigestive phase.
- Erythromycin for the prevention of chronic lung disease in intubated preterm infants at risk for, or colonized or infected with Ureaplasma urealyticum
Cochrane Systematic Reviews, 22-Oct-2008
Controversy exists over whether or not Ureaplasma urealyticum colonization or infection of the respiratory tract contributes to the severity of chronic lung disease (CLD), a major cause of morbidity and mortality in preterm infants.
- Erythropoiesis-stimulating agents for anaemia in adults with chronic kidney disease: a network meta-analysis
Cochrane Systematic Reviews, 3-Dec-2014
Several erythropoiesis-stimulating agents (ESAs) are available for treating anaemia in people with chronic kidney disease (CKD). Their relative efficacy (preventing blood transfusions and reducing fatigue and breathlessness) and safety (mortality and card
- Erythropoiesis-stimulating agents for anaemia in chronic heart failure patients
Cochrane Systematic Reviews, 9-Dec-2009
Chronic heart failure (CHF) is a leading cause of morbidity and mortality worldwide. Anaemia is a common (12-55%) co-morbid condition and is associated with worsening symptoms and increased mortality. Anaemia is treatable and can be targeted in the treatm
- Erythropoiesis-stimulating agents for anemia in rheumatoid arthritis
Cochrane Systematic Reviews, 22-Jan-2013
Rheumatoid arthritis (RA) is a chronic and systemic inflammatory disorder that mainly affects the small joints of the hands and feet. Erythropoiesis-stimulating agents have been used to treat anemia, one of the extra-articular manifestations of RA. Althou
- Erythropoietin as an adjuvant treatment with (chemo) radiation therapy for head and neck cancer
Cochrane Systematic Reviews, 12-May-2009
Tumour hypoxia increases tumour invasiveness and has a negative impact on response to therapy. Hypoxic tumours are also associated with severely anaemic individuals. It has therefore been hypothesised that correcting anaemia, by increasing haemoglobin lev
- Erythropoietin or darbepoetin for patients with cancer
Cochrane Systematic Reviews, 5-Nov-2012
Anaemia associated with cancer and cancer therapy is an important clinical factor in the treatment of malignant diseases. Therapeutic alternatives are recombinant human erythropoiesis stimulating agents (ESAs) and red blood cell transfusions.
- Erythropoietin or Darbepoetin for patients with cancer - meta-analysis based on individual patient data
Cochrane Systematic Reviews, 29-Sep-2010
Erythropoiesis-stimulating agents (ESAs) reduce anemia in cancer patients and may improve quality of life, but there are concerns that ESAs might increase mortality.
- Erythropoietin plus iron versus control treatment including placebo or iron for preoperative anaemic adults undergoing non‐cardiac surgery
Cochrane Systematic Reviews, 13-Aug-2020
Approximately 30% of adults undergoing non-cardiac surgery suffer from preoperative anaemia. Preoperative anaemia is a risk factor for mortality and adverse outcomes in different surgical specialties and is frequently the reason for blood transfusion. The
- Escitalopram versus other antidepressive agents for depression
Cochrane Systematic Reviews, 12-Aug-2009
Although pharmacological and psychological interventions are both effective for major depression, antidepressant drugs remain the mainstay of treatment in primary and secondary care settings. During the last 20 years, antidepressant prescribing has risen
